Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
BeiGene, the Beijing novel oncology drug developer, has...
Innovent Biologics of Suzhou raised $260 million in a...
The Medtronic-Sequoia China Healthcare Technology Venture...
BeiGene of Beijing is forming a $330 million JV, BeiGene...
Zai Lab of Shanghai partnered with GE Healthcare on...
Deals and Financings-- Beijing's BeiGene signed a record...
Shanghai's Zai Lab is planning a US IPO that could raise...
Suzhou's MabSpace Biosciences filed an IND application...
Innovent Biologics of Suzhou is planning a pre-IPO round...
Deals and Financings
Concord Medical Services...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
